{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:44:49Z","timestamp":1791830689521,"version":"4.3.4"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.2215\/cjn.03370414","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T00:10:49Z","timestamp":1413418249000},"page":"1930-1939","source":"Crossref","is-referenced-by-count":63,"title":["Intravenous Iron Exposure and Mortality in Patients on Hemodialysis"],"prefix":"10.2215","volume":"9","author":[{"given":"Dana C.","family":"Miskulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Tangri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bandeen-Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens B.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti L.","family":"Ephraim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieneke M.","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard G.","family":"Jaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidra C.","family":"Crews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia J.","family":"Scialla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Sozio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert W.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Ebony","family":"Boulware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20230601","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1053\/j.ajkd.2012.10.002","article-title":"The DOPPS Practice Monitor for US dialysis care: Trends through December 2011.","volume":"61","author":"Fuller","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R4-17-20230601","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ndt\/5.2.130","article-title":"Iron overload in haemodialysis patients increases the risk of bacteraemia: A prospective study.","volume":"5","author":"Boelaert","year":"1990","journal-title":"Nephrol Dial Transplant"},{"key":"R5-17-20230601","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/10408418809104468","article-title":"Iron and virulence in the family Enterobacteriaceae.","volume":"16","author":"Payne","year":"1988","journal-title":"Crit Rev Microbiol"},{"key":"R6-17-20230601","first-page":"1015","article-title":"Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis.","volume":"65","author":"Seifert","year":"1987","journal-title":"Q J Med"},{"key":"R7-17-20230601","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0025","article-title":"Pathobiology of the role of iron in infection.","volume":"34","author":"Sunder-Plassmann","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R8-17-20230601","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000035250.66458.67","article-title":"Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.","volume":"106","author":"Dr\u00fceke","year":"2002","journal-title":"Circulation"},{"key":"R9-17-20230601","doi-asserted-by":"crossref","first-page":"e50295","DOI":"10.1371\/journal.pone.0050295","article-title":"Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients.","volume":"7","author":"Kuo","year":"2012","journal-title":"PLoS ONE"},{"key":"R10-17-20230601","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1536\/ihj.46.255","article-title":"Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease.","volume":"46","author":"Reis","year":"2005","journal-title":"Int Heart J"},{"key":"R11-17-20230601","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2362.2002.0320s1009.x","article-title":"Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo.","volume":"32","author":"Rooyakkers","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"R12-17-20230601","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2215\/CJN.04190510","article-title":"Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease.","volume":"6","author":"Ferrari","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R13-17-20230601","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.amjmed.2012.01.015","article-title":"Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: A MRI study.","volume":"125","author":"Rostoker","year":"2012","journal-title":"Am J Med"},{"key":"R14-17-20230601","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1523-1755.2004.00480.x","article-title":"Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients.","volume":"65","author":"Canavese","year":"2004","journal-title":"Kidney Int"},{"key":"R15-17-20230601","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1681\/ASN.2012121164","article-title":"Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients.","volume":"24","author":"Brookhart","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R16-17-20230601","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/01.ASN.0000128009.69594.BE","article-title":"Administration of parenteral iron and mortality among hemodialysis patients.","volume":"15","author":"Feldman","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R17-17-20230601","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1681\/ASN.V133734","article-title":"Iron administration and clinical outcomes in hemodialysis patients.","volume":"13","author":"Feldman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R18-17-20230601","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1681\/ASN.2005040423","article-title":"Time-dependent associations between iron and mortality in hemodialysis patients.","volume":"16","author":"Kalantar-Zadeh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R19-17-20230601","doi-asserted-by":"crossref","first-page":"e78930","DOI":"10.1371\/journal.pone.0078930","article-title":"Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients.","volume":"8","author":"Kshirsagar","year":"2013","journal-title":"PLoS ONE"},{"key":"R20-17-20230601","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2369-13-167","article-title":"Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: The DEcIDE patient outcomes in end stage renal disease study.","volume":"13","author":"Boulware","year":"2012","journal-title":"BMC Nephrol"},{"key":"R21-17-20230601","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1471-2369-14-264","article-title":"Trends in anemia management in US hemodialysis patients 2004-2010.","volume":"14","author":"Miskulin","year":"2013","journal-title":"BMC Nephrol"},{"key":"R22-17-20230601","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.2009.413","article-title":"An improved comorbidity index for outcome analyses among dialysis patients.","volume":"77","author":"Liu","year":"2010","journal-title":"Kidney Int"},{"key":"R23-17-20230601","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.","volume":"11","author":"Hern\u00e1n","year":"2000","journal-title":"Epidemiology"},{"key":"R24-17-20230601","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology.","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"R25-17-20230601","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2307\/2529588","article-title":"Regression analysis of grouped survival data with application to breast cancer data.","volume":"34","author":"Prentice","year":"1978","journal-title":"Biometrics"},{"key":"R26-17-20230601","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models.","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"R27-17-20230601","doi-asserted-by":"crossref","first-page":"f4822","DOI":"10.1136\/bmj.f4822","article-title":"Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: Systematic review and meta-analysis of randomised clinical trials.","volume":"347","author":"Litton","year":"2013","journal-title":"BMJ"},{"key":"R29-17-20230601","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000074931","article-title":"Iron requirements in hemodialysis.","volume":"22","author":"Sargent","year":"2004","journal-title":"Blood Purif"},{"key":"R31-17-20230601","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0272-6386(99)70103-4","article-title":"A study of parenteral iron regimens in hemodialysis patients.","volume":"34","author":"Besarab","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R32-17-20230601","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5414\/CNP57136","article-title":"Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients.","volume":"57","author":"Chang","year":"2002","journal-title":"Clin Nephrol"},{"key":"R33-17-20230601","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5414\/CNP60335","article-title":"Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patients.","volume":"60","author":"DeVita","year":"2003","journal-title":"Clin Nephrol"},{"key":"R34-17-20230601","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0272-6386(95)90151-5","article-title":"Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.","volume":"26","author":"Fishbane","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"R35-17-20230601","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/ki.1996.487","article-title":"A randomized controlled study of iron supplementation in patients treated with erythropoietin.","volume":"50","author":"Macdougall","year":"1996","journal-title":"Kidney Int"},{"key":"R36-17-20230601","first-page":"2070","article-title":"Importance of iron supply for erythropoietin therapy.","volume":"10","author":"Sunder-Plassmann","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"R37-17-20230601","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the Dialysis Patients\u2019 Response to IV Iron with Elevated Ferritin (DRIVE) Study.","volume":"18","author":"Coyne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R38-17-20230601","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1681\/ASN.2007050606","article-title":"Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.","volume":"19","author":"Kapoian","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R40-17-20230601","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJMp0912328","article-title":"Erythropoiesis-stimulating agents\u2014time for a reevaluation.","volume":"362","author":"Unger","year":"2010","journal-title":"N Engl J Med"},{"key":"R41-17-20230601","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ki.2008.295","article-title":"Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.","volume":"74","author":"Szczech","year":"2008","journal-title":"Kidney Int"},{"key":"R42-17-20230601","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev.nu.06.070186.000305","article-title":"Biochemical basis for the manifestations of iron deficiency.","volume":"6","author":"Dallman","year":"1986","journal-title":"Annu Rev Nutr"},{"key":"R43-17-20230601","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1172\/JCI105269","article-title":"Myoglobin and cytochrome response during repair of iron deficiency in the rat.","volume":"44","author":"Dallman","year":"1965","journal-title":"J Clin Invest"},{"key":"R44-17-20230601","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/CS20040278","article-title":"Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: Involvement of nitric oxide synthase and protein tyrosine nitration.","volume":"109","author":"Dong","year":"2005","journal-title":"Clin Sci (Lond"},{"key":"R45-17-20230601","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency.","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"R46-17-20230601","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/eurheartj\/ehr504","article-title":"The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: A subanalysis of the FAIR-HF study.","volume":"34","author":"Comin-Colet","year":"2013","journal-title":"Eur Heart J"},{"key":"R47-17-20230601","doi-asserted-by":"crossref","first-page":"e87231","DOI":"10.1371\/journal.pone.0087231","article-title":"The relationship of initial transferrin saturation to cardiovascular parameters and outcomes in patients initiating dialysis.","volume":"9","author":"Koo","year":"2014","journal-title":"PLoS ONE"},{"key":"R48-17-20230601","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/j.ajkd.2008.05.029","article-title":"Erythropoietin, iron depletion, and relative thrombocytosis: A possible explanation for hemoglobin-survival paradox in hemodialysis.","volume":"52","author":"Streja","year":"2008","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201411000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:46Z","timestamp":1786369486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201411000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.03370414","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}